Short answer · Medically reviewed summary · Last updated: 2026-04-07
Fibromuscular dysplasia (FMD) is a non-inflammatory, non-atherosclerotic vascular disease that causes abnormal cell growth in the walls of medium-sized arteries, potentially leading to narrowing, aneurysms, or dissections. While it most commonly affects the renal and carotid arteries, it can involve any artery in the body, often resulting in high blood pressure or other vascular complications. What exactly happens in the body with Fibromuscular dysplasia? In patients with Fibromuscular dysplasia, the arterial wall undergoes structural changes where cells grow abnormally, causing the vessel to look like a "string of beads" on imaging.
2 people with Fibromuscular dysplasia have shared their first-person experience on this question at DiseaseMaps.
Fibromuscular dysplasia (FMD) is a non-inflammatory, non-atherosclerotic vascular disease that causes abnormal cell growth in the walls of medium-sized arteries, potentially leading to narrowing, aneurysms, or dissections. While it most commonly affects the renal and carotid arteries, it can involve any artery in the body, often resulting in high blood pressure or other vascular complications.
In patients with Fibromuscular dysplasia, the arterial wall undergoes structural changes where cells grow abnormally, causing the vessel to look like a "string of beads" on imaging. This process is distinct from atherosclerosis, which is caused by plaque buildup. Because the artery wall becomes weakened or narrowed, blood flow can be restricted, or the vessel may become prone to tears (dissection) or ballooning (aneurysms). The 132 members currently in the DiseaseMaps community often report that these vascular changes lead to symptoms ranging from pulsatile tinnitus and headaches to secondary hypertension.
Clinicians classify Fibromuscular dysplasia based on the layer of the artery wall that is most affected:
Data from the NIH and other clinical registries indicate that Fibromuscular dysplasia predominantly affects women, who account for approximately 90% of diagnosed cases. While the exact prevalence is difficult to determine because many cases remain asymptomatic, it is estimated to affect roughly 3 to 5 per 1,000 individuals in the general population. The condition is typically diagnosed in adults between the ages of 40 and 60, though it can be identified at any stage of life.
Unlike atherosclerosis, which is linked to cholesterol, smoking, and aging, Fibromuscular dysplasia is not caused by lifestyle factors or diet. A key differentiating factor is that FMD patients often have otherwise "clean" arteries without the systemic plaque buildup seen in traditional heart disease. Furthermore, the genetic component of Fibromuscular dysplasia is an active area of research; while it is not strictly hereditary in a simple Mendelian sense, there is evidence of familial clustering, suggesting a complex genetic predisposition.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.